Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

A new study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

People at high risk of acute myeloid leukaemia (AML) can be identified years in advance, but there is currently no treatment ...

Research doesn't happen by accident. Clinical trials don't appear overnight. Every treatment we use at the bedside starts ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

RAPID-CRISPR test quickly and accurately diagnoses acute promyelocytic leukemia, a rare and aggressive blood cancer, with ...

The author and screenwriter's disease was preceded by myelodyplastic syndrome (MDS), a stem cell disorder with flu-like symptoms. Instead of telling ... Since 2012, when acute myeloid leukemia (AML) ...

Acute myeloid leukemia (AML) is a cancer that impacts the blood and bone marrow ... This overproduction crowds out normal blood cells, leading to symptoms such as fatigue, frequent infections, and ...